GHIF Leads €16 Million Series B Financing for Univercells
Investment proceeds will support commercialization of the company’s breakthrough biologics manufacturing technology Univercells SA (‘Univercells’) and Global Health Investment Fund (‘GHIF’) are pleased to announce the closing of a €16 million ($18.8 million) Series B equity financing. Investment proceeds will support the continued development of Univercells’ game-changing biomanufacturing technology, which has the potential to dramatically [...]